Highlights of the May 6 (Part 1 of 2) issue
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsy
The authors report the long-term efficacy and tolerance of gamma knife in the treatment of mesial temporal lobe epilepsy. Good results were obtained in about 60% of patients. No long-term deleterious effects were reported. This study shows that GK constitutes a potential alternative to standard surgery in patients with mesial temporal lobe epilepsy.
See p. 1658; Editorial, p. 1654
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
The authors demonstrate that levels of plasma β-amyloid can be influenced by age, systemic vascular disease, and silent CNS vascular disease. They found that once these factors are accounted …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Brief Communications
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystoniaJ. Jankovic, K.D. Vuong, J. Ahsan et al.Neurology, April 08, 2003 -
Special Article
Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review)Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology SocietyM. R. Delgado, D. Hirtz, M. Aisen et al.Neurology, January 25, 2010 -
Articles
Botulinum toxin type A in the treatment of upper extremity spasticityA randomized, double‐blind, placebo‐controlled trialD. M. Simpson, D. N. Alexander, C. F. O'Brien et al.Neurology, May 01, 1996 -
Brief Communications
Botulinum toxin treatment of essential head tremorR. Pahwa, K. Busenbark, E. F. Swanson-Hyland et al.Neurology, April 01, 1995